HCV-infected individuals have higher prevalence of comorbidity and multimorbidity: a retrospective cohort study.
Curtis L CooperChrissi GalanakisJessy DonelleJeff KwongRob BoydLisa BoucherClaire E KendallPublished in: BMC infectious diseases (2019)
People with HCV have a higher prevalence of comorbidity and multimorbidity compared to the general population. While HCV treatment was not associated with multimorbidity, people with substance use disorder were less likely to be treated. Our results point to the need for integrated, comprehensive models of care delivery for people with HCV.